The use of lymphocytes and cytogenetics immunophenotypisation in evaluation of prognosis of patients with B-chronic lymphocytic leukemia;Použití imunofenotypizace lymfocytů a cytogenetiky při zpřesnění prognózy u pacientů s chronickou lymfatickou leukémií B typu

Casopis Lekaru Ceskych

Volumn 142, Issue 2, 2003, Pages 106-111

  Cmunt, Eduard ^a   Michalova K ^b   Karban, J ^a   Zemanova Z ^b   Sindelarova L ^b   Bosakova Z ^c   Brezinovae J ^d   Kurkova S ^d   Schwarz, J ^d  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c Mtnisterstvo Prace a Soc Veci CR   (Czech Republic)

^d INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

Author keywords

Chronic lymphocytic leukemia B type (B CLL); Fluorescence in situ hybridisation (FISH); Imunofenotypisation; Prognosis

Indexed keywords

CD38 ANTIGEN; GLYCOPROTEIN P 15095;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; B CELL LEUKEMIA; BONE MARROW CELL; CELL INFILTRATION; CHROMOSOME 11Q; CHROMOSOME 13Q; CHROMOSOME 17P; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CYTOGENETICS; DISEASE COURSE; EVALUATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; HUMAN; IMMUNOPHENOTYPING; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL CIRCULATION; PROGNOSIS; SAMPLING; STATISTICAL ANALYSIS; TRISOMY 12; CHROMOSOME ABERRATION; GENETICS; IMMUNOLOGY; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, B-CELL, CHRONIC; MALE; MIDDLE AGED; PROGNOSIS;

EID: 0037227736     PISSN: 00087335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Autio, K., Turunen, O., Penttilä, O., Erämaa, E. et al.: Human chronic lymphocytic leukemia: karyotypes in different lymphocyte populations. Cancer Genet Cytogenet., 1, 1979, s. 147-155.
2. Binet, J. L., Leporrier, M., Dighiero, G. et al.: A clinical staging system for chronic lymphocytic leukemia. Prognostic significance, Cancer, 40, 1977, s. 855-864.
3. Catovsky, D., Oscier, D. G., Einhorn, S., Garcia-Marco, J. A.: Cellular/cytogenetic events in CLL, Leuk. Lymph., 22, 1995, s. 41-45.
4. Damle, R. N., Wasil, T., Fais, F. et al.: IgV gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood, 94, 1999, s. 1840-1847.
5. Dighiero, G., Binet, J.-L.: When and how to treat chronic lymphocytic leukemia. N. Engl. J. Med., 343, 2000, s. 1799-1802.
6. DiGiuseppe, J. A., Borowitz, M. J.: Clinical utility of flow cytometry in the chronic lymphoid leukemias. Semin. Oncol., 25, 1998, s. 6-10.
7. Döhner, H., Stilgenbauer, S., James, M. R. et al.: 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood, 89, 1997, s. 2516-2522.
8. Döhner, H., Stilbenbauer, S., Döhner, K. et al.: Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis. J. Mol. Med., 77, 1999, s. 266-281.
9. Döhner, H., Stiblenbauer, S., Benner, A. et al.: Genomic aberrations and survival in chronic lymphocyte leukemia. N. Engl. J. Med., 343, 2000, s. 1910-1916.
10. Eckschlager, T. et al.: Průtoková cytometrie v klinické praxi. Grada Publishing, Praha 1999.
11. Fitchett, M., Griffith, S., Oscier, D. G. et al.: Chromosome abnormalities involving band 13q14 in hematologic malignancies. Cancer Genet. Cytogenet., 24, 1987, s. 143-150.
12. Gahrton, G., Robert, K. H., Friedberg, K. et al.: Nonrandom chromosomal aberration in chronic lymphocytic leukemia revealed by polyclonal B-cell mitogen stimulation. Blood, 56, 1980, s. 640-647.
13. Geisler, C. H., Larsen, J. K., Hansen, N. E. et al.: Prognostic importance of flow cytometric imunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia. Blood, 78 (7), 1991, s. 1795-1802.
14. H genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood, 94, 1999, s. 1848-1854.
15. Hurley, J. N., Fu, S., Kunkel, H. G. et al.: Chromosome abnormalities of leukemic B lymphocytes in chronic lymphocytic leukemia. Nature, 283, 1980, s. 76-79.
16. Jarošová, M., Jedličková, K., Holzerová, M. et al.: Přínos meted molekulární cytogenetiky pro určení prognosticky významných chromozomových změn u nemocných s chronickou lymfatickou leukémií. Čas. Lék. čes., 18, 2000, s. 564-569.
17. Juliusson, G., Merup, M.: Cytogenetics in chronic lymphocytic leukemia. Semin. Oncol., 25, 1998, s. 19-26.
18. Juliusson, G., Oscier, D., Gahrton, G. for the International Working Party on Chromosomes in CLL (IWCLL): Cytogenetic findings and survival in B-cell chronic lymphocytic leukemia. Second IWCLL compilation of data on 662 patients. Leuk. Lymphoma, 5, 1991, s. 21-25.
19. Kalil, N., Cheson, B. D.: Management of chronic lymphocytic leukemia. Drugs Aging, 16, 2000, s. 9-27.
20. Migliazza, A., Bosch, F., Komatsu, H. et al.: Nucleotide sequence, transcription map and mutational analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia. Blood, 97, 2001, s. 2098-2104.
21. Michalová, K.: Fluorescenční in situ hybridizace (FISH) v klinické cytogenetice. Čas. Lék. čes., 134, 1995, s. 73-76.
22. Michalová, K., Zemanová, Z., Cmunt, E., Karban, J. et al.: Význam interfázické fluorescenční in situ hybridizace (I-FISH) pro vyšetření nemocných s chronickou lymfatickou leukémií. Čas. Lék. čes., 139, 2000, s. 334-338.
23. Michalová, K., Zemanová, Z., Cmunt, E. et al.: Molekulární cytogenetická diagnostika u chronických lymfatických leukémií (závěrečná zpráva o řešení grantu IGA MU ČR 5010-3). Praha 2001.
24. Neilson, J. R., Auer, R., White, D. et al.: Deletions at 11q identify a subset of patients with typical CLL who show consistent disease progression and reduced survival. Leukemia, 11, 1997, s. 1929-1932.
25. Rai, K. R., Sawitzky, A., Cronkite, E. P. et al.: Clinical staging of chronic lymphocytic leukemia. Blood, 46, 1975, s. 219-234.
26. Ross, F. M., Stockdill, G.: Clonal chromosome abnormalities in chronic lymphocytic leukemia patients revealed by TPA stimulation of whole blood cultures. Cancer Genet. Cytogenet., 25, 1987, s. 109-121.
27. Schaffner, C., Stilgenbauer, S., Rappold, G. A. et al.: Somatic ATM mutations indicate a pathogenic role of ATM in B-cell lymphocytic leukemia. Blood, 94 (2), 1999, s. 748-753.
28. Senderowicz, A. M.: Development of cyclin-dependent kinase modulators as novel therapeutic approaches for hematological malignancies. Leukemia, 15 (1), 2001, s. 1-9.
29. Seymour, J. F., Cusack, J. D., Lerner, S. A. et al.: Case control study of the role of splenectomy in chronic lymphocytic leukemia. J. Clin. Oncol., 15, 1997, s. 52-60.